
Revenue
FY, 2026
| INR | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 | FY, 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 971.0M | 1.4B | 1.6B | 1.6B | 1.8B | 2.2B | 2.5B | 3.0B | 6.0B |
| Cost of goods sold | 402.8M | 625.5M | 622.7M | 636.8M | 678.1M | 834.7M | 944.0M | 1.0B | 1.1B |
| Gross profit | 616.0M | 891.9M | 1.1B | 1.0B | 1.1B | 1.4B | 1.6B | 2.1B | 5.4B |
| Gross profit margin, % | 63.4% | 62.1% | 66.5% | 64.0% | 64.4% | 63.6% | 65.5% | 68.4% | 89.1% |
| Operating expense total | 452.8M | 645.5M | 775.4M | 646.5M | 690.4M | 756.0M | 897.2M | 1.3B | 3.7B |
| Depreciation and amortization | 57.7M | 90.9M | 102.1M | 143.8M | 146.3M | 166.7M | 166.3M | 216.0M | 366.9M |
| EBITDA | 163.1M | 246.4M | 286.9M | 366.4M | 444.9M | 610.5M | 749.6M | 767.5M | 1.7B |
| EBITDA margin, % | 16.8% | 17.2% | 18.0% | 23.2% | 25.2% | 28.4% | 29.8% | 25.3% | 28.6% |
| EBIT | 105.0M | 149.3M | 184.8M | 222.5M | 282.9M | 443.8M | 583.3M | 542.0M | 1.4B |
| EBIT margin, % | 10.8% | 10.4% | 11.6% | 14.1% | 16.0% | 20.6% | 23.2% | 17.9% | 22.5% |
| Interest income | 809.0K | 1.2M | 11.0M | 1.4M | 1.5M | 7.2M | 43.1M | 265.3M | |
| Interest expense | 40.2M | 92.1M | 113.9M | 134.3M | 151.7M | 157.8M | 152.5M | 89.0M | 86.4M |
| Pre tax profit | 84.9M | 94.2M | 139.0M | 122.9M | 170.2M | 336.6M | 541.5M | 782.7M | 1.3B |
| Income tax expense | 10.5M | (14.9M) | 33.9M | 79.4M | 42.1M | 78.4M | 119.3M | 172.6M | 253.9M |
| Net Income | 74.4M | 109.2M | 105.1M | 43.5M | 128.1M | 258.2M | 422.2M | 610.2M | 1.0B |
| Company name | Date | Deal size |
|---|---|---|
| Lorem | Dec 23, 2021 | $40.0M |
| Ipsum | Jan 18, 2022 | $30.0M |
| Lorem Ipsum | Feb 18, 2022 | $25.0M |
| Dolor | Oct 21, 2021 | $60.0M |
Premium Content only available in Craft’s Intelligence Portal View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more |